Form 8-K - Current report:
SEC Accession No. 0001104659-24-101892
Filing Date
2024-09-23
Accepted
2024-09-23 08:10:25
Documents
64
Period of Report
2024-09-23
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2424516d1_8k.htm   iXBRL 8-K 31674
2 EXHIBIT 99.1 tm2424516d1_ex99-1.htm EX-99.1 74581
3 EXHIBIT 99.2 tm2424516d1_ex99-2.htm EX-99.2 14485
7 GRAPHIC tm2424516d1_ex99-2img01.jpg GRAPHIC 3468
8 GRAPHIC tm2424516d1_ex99-1img001.jpg GRAPHIC 173283
9 GRAPHIC tm2424516d1_ex99-1img002.jpg GRAPHIC 355888
10 GRAPHIC tm2424516d1_ex99-1img003.jpg GRAPHIC 192867
11 GRAPHIC tm2424516d1_ex99-1img004.jpg GRAPHIC 187117
12 GRAPHIC tm2424516d1_ex99-1img005.jpg GRAPHIC 165282
13 GRAPHIC tm2424516d1_ex99-1img006.jpg GRAPHIC 214373
14 GRAPHIC tm2424516d1_ex99-1img007.jpg GRAPHIC 206702
15 GRAPHIC tm2424516d1_ex99-1img008.jpg GRAPHIC 247789
16 GRAPHIC tm2424516d1_ex99-1img009.jpg GRAPHIC 190115
17 GRAPHIC tm2424516d1_ex99-1img010.jpg GRAPHIC 224456
18 GRAPHIC tm2424516d1_ex99-1img011.jpg GRAPHIC 173782
19 GRAPHIC tm2424516d1_ex99-1img012.jpg GRAPHIC 210881
20 GRAPHIC tm2424516d1_ex99-1img013.jpg GRAPHIC 223374
21 GRAPHIC tm2424516d1_ex99-1img014.jpg GRAPHIC 199945
22 GRAPHIC tm2424516d1_ex99-1img015.jpg GRAPHIC 230565
23 GRAPHIC tm2424516d1_ex99-1img016.jpg GRAPHIC 126202
24 GRAPHIC tm2424516d1_ex99-1img017.jpg GRAPHIC 190905
25 GRAPHIC tm2424516d1_ex99-1img018.jpg GRAPHIC 191144
26 GRAPHIC tm2424516d1_ex99-1img019.jpg GRAPHIC 159880
27 GRAPHIC tm2424516d1_ex99-1img020.jpg GRAPHIC 177615
28 GRAPHIC tm2424516d1_ex99-1img021.jpg GRAPHIC 214468
29 GRAPHIC tm2424516d1_ex99-1img022.jpg GRAPHIC 192777
30 GRAPHIC tm2424516d1_ex99-1img023.jpg GRAPHIC 228932
31 GRAPHIC tm2424516d1_ex99-1img024.jpg GRAPHIC 236037
32 GRAPHIC tm2424516d1_ex99-1img025.jpg GRAPHIC 179194
33 GRAPHIC tm2424516d1_ex99-1img026.jpg GRAPHIC 242792
34 GRAPHIC tm2424516d1_ex99-1img027.jpg GRAPHIC 205605
35 GRAPHIC tm2424516d1_ex99-1img028.jpg GRAPHIC 222304
36 GRAPHIC tm2424516d1_ex99-1img029.jpg GRAPHIC 177675
37 GRAPHIC tm2424516d1_ex99-1img030.jpg GRAPHIC 178283
38 GRAPHIC tm2424516d1_ex99-1img031.jpg GRAPHIC 207163
39 GRAPHIC tm2424516d1_ex99-1img032.jpg GRAPHIC 165815
40 GRAPHIC tm2424516d1_ex99-1img033.jpg GRAPHIC 198989
41 GRAPHIC tm2424516d1_ex99-1img034.jpg GRAPHIC 253764
42 GRAPHIC tm2424516d1_ex99-1img035.jpg GRAPHIC 192047
43 GRAPHIC tm2424516d1_ex99-1img036.jpg GRAPHIC 176607
44 GRAPHIC tm2424516d1_ex99-1img037.jpg GRAPHIC 199920
45 GRAPHIC tm2424516d1_ex99-1img038.jpg GRAPHIC 220443
46 GRAPHIC tm2424516d1_ex99-1img039.jpg GRAPHIC 220860
47 GRAPHIC tm2424516d1_ex99-1img040.jpg GRAPHIC 185056
48 GRAPHIC tm2424516d1_ex99-1img041.jpg GRAPHIC 183076
49 GRAPHIC tm2424516d1_ex99-1img042.jpg GRAPHIC 211496
50 GRAPHIC tm2424516d1_ex99-1img043.jpg GRAPHIC 176369
51 GRAPHIC tm2424516d1_ex99-1img044.jpg GRAPHIC 343674
52 GRAPHIC tm2424516d1_ex99-1img045.jpg GRAPHIC 305546
53 GRAPHIC tm2424516d1_ex99-1img046.jpg GRAPHIC 211000
54 GRAPHIC tm2424516d1_ex99-1img047.jpg GRAPHIC 269845
55 GRAPHIC tm2424516d1_ex99-1img048.jpg GRAPHIC 236078
  Complete submission text file 0001104659-24-101892.txt   14224494

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA syn-20240923.xsd EX-101.SCH 3042
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE syn-20240923_lab.xml EX-101.LAB 34240
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE syn-20240923_pre.xml EX-101.PRE 22378
66 EXTRACTED XBRL INSTANCE DOCUMENT tm2424516d1_8k_htm.xml XML 3692
Mailing Address 9605 MEDICAL CENTER DRIVE SUITE 270 ROCKVILLE MD 20850
Business Address 9605 MEDICAL CENTER DRIVE SUITE 270 ROCKVILLE MD 20850 (734) 332-7800
Theriva Biologics, Inc. (Filer) CIK: 0000894158 (see all company filings)

EIN.: 133808303 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-12584 | Film No.: 241314669
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)